A new study from three research facilities in Ostrava demonstrates the potential of artificial intelligence to significantly improve the detection of subtle changes in the brain caused by multiple sclerosis (MS). Researchers compared two MRI systems used to monitor MS activity and found AI enhanced the ability to identify even the smallest indicators of the disease. This advancement promises more accurate and earlier diagnoses of MS. The findings suggest AI can aid in tracking disease progression and potentially personalize treatment plans. By analyzing MRI scans with greater precision, AI offers a valuable tool for neurologists. The study highlights the growing role of AI in medical imaging and disease management, offering hope for improved patient outcomes.